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Introduction 
Pulmonary thromboembolism is a common cause of in-hospital death; without thrombo-
prophylaxis, the incidence of hospital-acquired venous thrombosis is around 10-40% in 
surgically treated patients [1]. According to other estimates, the incidence of fatal pulmo-
nary embolism is generally  0.1-0.8% in patients undergoing elective general surgery [2]. 
Acute and long term mortality rates can be effectively reduced through diverse treatment 
strategies depending on the risk levels of the individual patients (high or moderate): a 
large number of randomized clinical trials have shown an irrefutable reduction in venous 
thrombosis and pulmonary thromboembolism cases with the application of a thrombo-
prophylactic drug treatment protocol. Despite the complications associated with anti-
thrombotic therapies, such trials have also shown small or non-increased rates of bleed-
ing associated with prophylactic use of low-dose unfractionated heparin (LDUH) or low 
molecular weight heparin (LMWH) [3].  
Although laparoscopy is now considered the preferred surgical technique, the correlation 
between the risk of thromboembolism and such procedure is currently unclear, and thus 
the use of thromboprophylaxis remains controversial [1, 2, 4] .  
The percentage of cases with venous thromboembolism following laparoscopic surgery 
appears to be low, as confirmed by some studies. Other authors, however, argue that 
laparoscopic surgery (such as laparotomy) increases the risk of developing thrombosis 
due to the increased abdominal pressure and the use of Trendelenderbug position [2]. 
Case Report 
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SUMMARY 
Pulmonary thromboembolism is a common cause of in-hospital death. In moderate or 
high risk patients undergoing laparotomy, acute and long-term mortality can be effec-
tively reduced with an appropriate prophylactic drug treatment, while in low-risk patients 
undergoing laparoscopy, the correlation between the thromboembolism risk and the pro-
cedure itself, as well as potential benefits of thromboprophylaxis are, at present, unclear. 
Here we report the case of E., a 49-year-old woman with patent foramen ovale, consid-
ered to be at low risk of thromboembolism, who experienced a sudden cardiopulmonary 
arrest following a laparoscopic cholecystectomy and died four days later.  . 
The purpose of this case report is to highlight the necessity of continuing large sample 
studies on the correlation between laparoscopic surgery and thromboembolism in low-
risk patients. 
Address of the authors 
* Department of Biopathology, Biotechnology and Forensic Medicine, University of Palermo 
** Department of Pathological Anatomy, University of Palermo 
*** Department of General Surgery - Oncological Surgery, University of Palermo 
**** Department of Occupational Medicine, University of Palermo 
 
 Send correspondence to: Valentina Triolo, dr.valentinatriolo@gmail.com 
 
Received: March 21th, 2013 — Revised: May 2nd, 2013 — Accepted: June 10th, 2013 
ISSN 2279-7165 - Euromediterranean Biomedical Journal [online] 
Case Report 
E., a 49-year-old woman, healthy apart 
from a prior diagnosis of type 2 diabetes, 
and, therefore, considered of a low opera-
tive risk, was subjected to laparoscopic 
cholecystectomy following an episode of 
acute cholecystitis. Prior to surgery, low 
molecular weight heparin was adminis-
tered in doses appropriate for her body 
weight; however, twenty-four hours later, 
respiratory failure with subsequent cardiac 
arrest manifested, followed by the recovery 
of the cardiac activity after resuscitation. 
The patient lapsed into a coma and was 
transferred to another hospital, where, 
following further medical investigation, 
including a brain and chest CT scan, elec-
troencephalogram, and full abdominal 
ultrasound scan, fulminant hepatitis was 
suspected. After four days, the patient died 
despite the cardio-respiratory maneuvers 
and emergency ventilatory support [5]. 
Autopsy findings revealed the absence of 
traumatic injury; a saddle pulmonary em-
bolism was detected together with a 
thrombus in the inferior vena cava; the 
lungs were deemed normal in terms of 
appearance and volume; edematous cut 
surface was observed. Numerous blood 
clots and/or emboli characterized by plate-
let (white) and glossy red components 
were observed in the heart, which was 
found otherwise normal in form and vol-
ume. The valve system appeared normal 
and a patent foramen ovale was observed. 
The liver, steatotic and with a slightly in-
creased volume, showed coagulative necro-
sis associated with hemorrhagic centrilobu-
lar steatosis and lymphocytic cholangitis. 
The main bile ducts were patent. The 
spleen displayed acute stasis and severe 
congestion was observed in the renal pa-
renchyma. The small intestine appears 
normal in its course, except in the iliac 
region where an  ischemic area was ob-
served. At the opening of the bowel, the 
presence of black fecal material occupying 
about three-quarters of the intestine was 
noted. 
Histological examination, using a hema-
toxylin-based stain, confirmed a massive 
pulmonary embolism (Figure 1), biventricu-
lar endomyocardial fibrosis with focal ne-
crotic evolution associated with granulo-
cyte infiltration, hepatic coagulation necro-
sis associated with steatosis, colliquative 
autolysis of the pancreas; acute ileal hem-
orrhage involving the mucosa, with cyto-
toxic edema, subcortical neuronal necrosis 
(involving the hippocampus and basal 
ganglia) and the presence of a leptomen-
ingeal septic embolus (Figure 2). 
 
Discussion 
At present, an increasing number of dis-
eases, especially of the liver, pancreas and 
bile ducts, are treated with laparoscopic 
surgery because this type of approach 
significantly reduces surgical stress. At the 
moment, there are no studies that clearly 
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Figure 1: Pulmonary artery - thrombotic 
material represented by platelets, erythro-
cytes and numerous neutrophils; in this 
context, colonies of bacteria are observed 
(arrow). A: x10. B and c: x20. 
Figure 2: Brain – septic emboli represented 
by vast leptomeningeal granulocytic infil-
tration. A: x10. B: x40.  
demonstrate an association between 
laparoscopic surgery and increased inci-
dence of thromboembolism, with the con-
sequent potential of thromboprophylaxis 
to reduce the risk of death or incidence of 
pulmonary embolism. 
In a review including 153.832 laparoscopic 
cholecystectomies in which thrombopro-
phylaxis protocols were employed, the 
average percentages of deep vein throm-
bosis, pulmonary embolism and fatal pul-
monary embolism cases were 0.03%, 
0.06% and 0.02%, respectively [6]. In a 
sample of 105.850 laparoscopic cholecys-
tectomies performed in California, the risk 
of symptomatic thromboembolism within 
three months from the procedure was 
0.2%, compared with 0.5% following tradi-
tional cholecystectomy surgery [7]. In 
addition, among 422 patients not sub-
jected to any type of thromboprophylaxis, 
only one developed symptoms associated 
with deep vein thrombosis. 
Several associations, such as the European 
Association for Endoscopic Surgery and 
the American College of Chest Physicians 
have expressed diverse opinions about the 
implementation of antithrombotic prophy-
laxis protocols in low-risk patients under-
going laparoscopy. 
Recently, some authors published research 
results showing that laparoscopic chole-
cystectomy can be considered a procedure 
at a low risk of thrombosis, and therefore 
the use of routine thromboprophylaxis is 
probably not justified in all patients; how-
ever, further studies should be carried to 
obtain irrefutable clinical confirmation for 
this hypothesis [4]. 
Most of the currently available studies 
recommend antithrombotic therapy only in 
the presence of major risk factors. 
There are several ways to stratify the risk 
of thromboembolism: one approach con-
siders the patient’s predisposing factors 
and the degree of risk associated with the 
procedure, while a second, more simplified 
approach assigns a score from one to four 
based on the type of operation (major or 
minor), patient age (less than 40, 40-60, 
over 60), and the presence of additional 
risk factors (such as the presence of can-
cer or previous cases of venous throm-
boembolism) [8]. 
In the present case, the patient, E., had a 
low embolic risk, no prior history of 
thrombotic events or comorbid conditions, 
was 49 years old, and the planned inter-
vention was considered a minor surgery. 
Nevertheless, the doctors decided to ad-
minister a thromboprophylaxis to the pa-
tient. Therefore, in our patient’s case, a 
low thrombosis risk combined with an 
appropriate prophylaxis did not eliminate 
the possibility of a pulmonary embolism. 
Alterations of the coagulation system are 
among the most frequent consequences of 
general surgery, and laparoscopic surgery 
is no exception.  
Further studies on larger samples are 
needed to gain a better understanding of 
the correlation between the incidence of 
thromboembolism and laparoscopic chole-
cystectomy, as well as the influence of 
“silent” birth defects (such as patent fora-
men ovale) and to define new guidelines 
for standardizing therapeutic procedures. 
The present clinical case also offers an-
other interesting piece of evidence: the 
presence of a septic brain embolus. This 
was probably caused by the patient’s pat-
ent foramen ovale [9]. Some authors show 
a higher incidence of neurological compli-
cations following laparoscopic surgery in 
patients with patent foramen ovale; this 
would seem to lead to the conclusion that 
these patients should be referred to a 
laparatomy procedure instead. However, in 
absence of in-depth studies, there are 
currently no clear indications specific to 
such situations. 
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